C section News and Research

RSS

Kindred Healthcare proposes to acquire all outstanding shares of Gentiva

Kindred Healthcare, Inc. ("Kindred" or the "Company") today announced a proposal to acquire all of the outstanding shares of common stock of Gentiva Health Services, Inc.

15 May 2014

‘Lessebo’ effect implications for Parkinson’s therapies

Patients with Parkinson’s disease have a reduced objective response to treatment given in a clinical trial if they know they may be taking a placebo, research shows.

14 May 2014

C-section delivery, early antibiotic treatment linked to eosinophilic esophagitis in children

Children delivered by cesarean section and those given antibiotics during early infancy appear more prone to developing allergic inflammation of the esophagus — the muscular tube that connects the mouth to the stomach — according to results of a study by investigators from the Johns Hopkins Children’s Center and Harvard Medical School.

13 May 2014

Beaumont Children's Hospital wins grant from CureSearch Children's Cancer to help fund therapeutic clinical trials

CureSearch for Children's Cancer has awarded a $20,000 grant to Beaumont Children's Hospital to help fund therapeutic clinical trials.

13 May 2014

State highlights: N.Y. Medicaid change and cash; Conn. mental health cops; Conn. mental health school outreach

A selection of health policy stories from New York, Connecticut and Minnesota. When Hurricane Sandy flooded two adult homes in Queens, hundreds of disabled, elderly or mentally ill residents were caught in the surge.

12 May 2014

Whitehead Institute scientists identify genetic cause of hemifacial microsomia

Whitehead Institute scientists have identified a genetic cause of a facial disorder known as hemifacial microsomia (HFM). The researchers find that duplication of the gene OTX2 induces HFM, the second-most common facial anomaly after cleft lip and palate.

12 May 2014

Antares Pharma reports total revenues of $5.2 million for first quarter 2014

Antares Pharma, Inc. today reported operating and financial results for the first quarter ended March 31, 2014.

9 May 2014

First Edition: May 9, 2014

Today's headlines include highlights from the first Senate confirmation hearing for Sylvia Mathews Burwell, President Barack Obama's pick for Health and Human Services Secretary.

9 May 2014

Comer Children's Hospital offers high-dose radiation therapy for relapsed neuroblastoma

The University of Chicago Medicine Comer Children's Hospital has become the first in Illinois to offer pioneering, targeted, high-dose, intravenous radiation therapy for relapsed neuroblastoma and other difficult-to-treat cancers.

9 May 2014

Scientists discover ancient kitten-sized predator that lived 13 million years ago

A Case Western Reserve University student and his mentor have discovered an ancient kitten-sized predator that lived in Bolivia about 13 million years ago-one of the smallest species reported in the extinct order Sparassodonta.

9 May 2014

Consumer Reports finds that only some hospitals help mothers avoid unnecessary C-sections

A Consumer Reports analysis of over 1,500 hospitals in 22 U.S. states suggests that some hospitals do a much better job than others at helping mothers avoid unnecessary C-sections.

8 May 2014

Expanding Medicaid access increases use of subspecialty surgical services in New York State

Researchers in the department of surgery at the University of Michigan have found that expanding access to Medicaid in New York State increased beneficiaries' use of subspecialty surgical services.

8 May 2014

3 pioneering cell biologists win 2014 E.B. Wilson Medal from American Society for Cell Biology

If cells were cars, then the three pioneering cell biologists just named winners of the 2014 E.B. Wilson Medal, the highest scientific honor of the American Society for Cell Biology, helped write the essential parts list.

8 May 2014

Targacept reports net loss of $11.6M in first quarter 2014

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the first quarter ended March 31, 2014.

7 May 2014

ARIAD provides update on corporate developments, reports Q1 2014 financial results

ARIAD Pharmaceuticals, Inc. today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.

7 May 2014

Humana reports EPS of $2.35 in Q1 2014; confirms EPS guidance for FY14

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended March 31, 2014 (1Q14) of $2.35, compared to diluted earnings per common share (EPS) of $2.95 for the quarter ended March 31, 2013 (1Q13).

7 May 2014

Surgical site infection guidelines provide real-world strategies to reduce number of infections

Surgical site infections (SSIs) are the most common and costly healthcare-associated infection (HAI) in the United States.

7 May 2014

NanoString receives license from Health Canada to market Prosigna Breast Cancer Prognostic Gene Signature Assay

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has received a Class III Medical Device License from Health Canada, clearing the company to market its Prosigna Breast Cancer Prognostic Gene Signature Assay for assessing a woman's 10-year risk of distant recurrence and accurately identifying the intrinsic biologic subtype of the tumor.

From NanoString Technologies 7 May 2014

Laparoscopic-assisted colonoscopy with polypectomy reduces hospital utilization

A surgical method combining two techniques for removing precancerous polyps during colonoscopies can substantially reduce the recovery time and the length of hospital stays, potentially saving the health-care system millions of dollars, according to research presented today at Digestive Disease Week- (DDW).

6 May 2014

Teva's SYNRIBO for injection receives FDA approval for home administration

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved SYNRIBO® (omacetaxine mepesuccinate) for injection, for subcutaneous use, to include home administration, and also approved a related Medication Guide and Instructions for Use.

6 May 2014

C section News and Research

Kindred Healthcare proposes to acquire all outstanding shares of Gentiva

‘Lessebo’ effect implications for Parkinson’s therapies

C-section delivery, early antibiotic treatment linked to eosinophilic esophagitis in children

Beaumont Children's Hospital wins grant from CureSearch Children's Cancer to help fund therapeutic clinical trials

State highlights: N.Y. Medicaid change and cash; Conn. mental health cops; Conn. mental health school outreach

Whitehead Institute scientists identify genetic cause of hemifacial microsomia

Antares Pharma reports total revenues of $5.2 million for first quarter 2014

First Edition: May 9, 2014

Comer Children's Hospital offers high-dose radiation therapy for relapsed neuroblastoma

Scientists discover ancient kitten-sized predator that lived 13 million years ago

Consumer Reports finds that only some hospitals help mothers avoid unnecessary C-sections

Expanding Medicaid access increases use of subspecialty surgical services in New York State

3 pioneering cell biologists win 2014 E.B. Wilson Medal from American Society for Cell Biology

Targacept reports net loss of $11.6M in first quarter 2014

ARIAD provides update on corporate developments, reports Q1 2014 financial results

Humana reports EPS of $2.35 in Q1 2014; confirms EPS guidance for FY14

Surgical site infection guidelines provide real-world strategies to reduce number of infections

NanoString receives license from Health Canada to market Prosigna Breast Cancer Prognostic Gene Signature Assay

Laparoscopic-assisted colonoscopy with polypectomy reduces hospital utilization

Teva's SYNRIBO for injection receives FDA approval for home administration

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News